Positive midstage trial results for Pfizer’s cancer cachexia drug | Health & Medicine
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer sufferers to lose their urge for food and weight confirmed optimistic results in a midstage trial, the drugmaker stated Saturday. Patients with the situation, known as cancer cachexia, who took Pfizer’s remedy noticed enhancements in physique weight, muscle mass, high quality of life and … Read more